Apellis Pharma CEO Francois sells $161,945 in stock
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Cruise Rivals, Starboard And Harding, Lay Retail Blueprints For 2026
Expected record demand for cruising this year has led the two biggest retail players—Starboard and Harding+—to fine-tune their strategies to lift onboard store sales.
Apellis Pharma VP Chopas sells $14k in shares
Post Content
Nicholson nur, Apellis Pharmaceuticals CTO, sells $43k in APLS stock
Post Content
Apellis Pharma CMO Baumal sells $37k in shares
Post Content
Okupe, CFO of Hims & Hers, sells $275k in HIMS stock
Post Content
Factbox-Goldman Sachs raises 2026-end gold price forecast to $5,400/oz
Post Content
Form 144 Procore Technologies For: 21 January
Post Content
Form 144 COMMERCE.COM For: 21 January
Post Content
Form 144 ALPHABET For: 21 January
Post Content